A – Females | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
 | Never | Former | Current | Missing | Total | |||||
 | No. | % | No. | % | No. | % | No. | % | No. | % |
Histology | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Non small cell lung carcinoma (NSCLC) | 101 | 87.8 | 96 | 78.0 | 146 | 73.0 | 10 | 90.9 | 353 | 78.6 |
   Adenocarcinoma | 85 | 73.9 | 64 | 52.0 | 90 | 45.0 | 5 | 45.4 | 244 | 54.3 |
   Squamous cell | 7 | 6.1 | 19 | 15.4 | 22 | 11.0 | 1 | 9.1 | 49 | 10.9 |
   Large cell | 2 | 1.7 | 6 | 4.9 | 12 | 6.0 | 0 | - | 20 | 4.5 |
   NSCLC, not defined | 7 | 6.1 | 7 | 5.7 | 22 | 11.0 | 4 | 36.4 | 40 | 8.9 |
Small cell carcinoma | 3 | 2.6 | 8 | 6.5 | 29 | 14.5 | 0 | 0.0 | 40 | 8.9 |
Others (mixed types) | 5 | 4.4 | 13 | 10.6 | 18 | 9.0 | 1 | 9.1 | 37 | 8.2 |
Missing | 6 | 5.2 | 6 | 4.9 | 7 | 3.5 | 0 | 0.0 | 19 | 4.2 |
Stage | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
   IA | 11 | 9.6 | 13 | 10.6 | 20 | 10.0 | 2 | 18.2 | 46 | 10.2 |
   IB | 14 | 12.2 | 13 | 10.6 | 23 | 11.5 | 0 | 0.0 | 50 | 11.1 |
   IIA | 0 | 0.0 | 3 | 2.4 | 3 | 1.5 | 1 | 9.1 | 7 | 1.6 |
   IIB | 10 | 8.7 | 10 | 8.1 | 14 | 7.0 | 0 | 0.0 | 34 | 7.6 |
   IIIA | 13 | 11.3 | 18 | 14.6 | 26 | 13.0 | 0 | 0.0 | 57 | 12.7 |
   IIIB | 18 | 15.6 | 15 | 12.2 | 28 | 14.0 | 3 | 27.3 | 64 | 14.3 |
   IV | 48 | 41.7 | 50 | 40.7 | 81 | 40.5 | 5 | 45.4 | 184 | 41.0 |
   X | 1 | 0.9 | 1 | 0.8 | 5 | 2.5 | 0 | 0.0 | 7 | 1.6 |
Total | 115 | 100.0 | 123 | 100.0 | 200 | 100.0 | 11 | 100.0 | 449 | 100.0 |
B – Males | ||||||||||
 | Never | Former | Current | Missing | Total | |||||
 | No. | % | No. | % | No. | % | No. | % | No. | % |
Histology | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Non small cell lung carcinoma (NSCLC) | 28 | 84.9 | 607 | 80.0 | 662 | 79.0 | 14 | 60.9 | 1311 | 79.4 |
   Adenocarcinoma | 20 | 60.6 | 283 | 37.3 | 305 | 36.4 | 6 | 26.1 | 614 | 37.2 |
   Squamous cell | 5 | 15.2 | 233 | 30.7 | 241 | 28.8 | 5 | 21.7 | 484 | 29.3 |
   Large cell | 0 | 0.0 | 23 | 3.0 | 33 | 3.9 | 1 | 4.4 | 57 | 3.5 |
   NSCLC, not defined | 3 | 9.1 | 68 | 9.0 | 83 | 9.9 | 2 | 8.7 | 156 | 9.4 |
Small cell carcinoma | 1 | 3.0 | 73 | 9.6 | 100 | 11.9 | 2 | 8.7 | 176 | 10.7 |
Others (mixed types) | 1 | 3.0 | 39 | 5.2 | 38 | 4.5 | 2 | 8.7 | 80 | 4.8 |
Missing | 3 | 9.1 | 39 | 5.2 | 38 | 4.5 | 5 | 21.7 | 85 | 5.1 |
Stage | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   0 | 0 | 0.0 | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 | 1 | 0.1 |
   IA | 3 | 9.1 | 78 | 10.3 | 59 | 7.0 | 1 | 4.4 | 141 | 8.5 |
   IB | 1 | 3.0 | 109 | 14.4 | 93 | 11.1 | 2 | 8.7 | 205 | 12.4 |
   IIA | 0 | 0.0 | 11 | 1.4 | 11 | 1.3 | 0 | 0.0 | 22 | 1.3 |
   IIB | 4 | 12.1 | 65 | 8.6 | 76 | 9.1 | 1 | 4.4 | 146 | 8.8 |
   IIIA | 1 | 3.0 | 78 | 10.3 | 97 | 11.6 | 1 | 4.4 | 177 | 10.7 |
   IIIB | 4 | 12.1 | 102 | 13.5 | 150 | 17.9 | 3 | 13.0 | 259 | 15.7 |
   IV | 20 | 60.6 | 295 | 38.9 | 331 | 39.5 | 14 | 60.9 | 660 | 40.0 |
   X | 0 | 0.0 | 19 | 2.5 | 21 | 2.5 | 1 | 4.4 | 41 | 2.5 |
Total | 33 | 100.0 | 758 | 100.0 | 838 | 100.0 | 23 | 100.0 | 1652 | 100.0 |